Stephen Allen Hurly
Chief Executive Officer bij LAVA THERAPEUTICS N.V.
Vermogen: 16 650 $ op 31-03-2024
Profiel
Stephen Allen Hurly is currently the President, CEO, Executive Director & MD at LAVA Therapeutics NV since 2019.
He is also the Director at Phusis Therapeutics, Inc. since 2011.
Previously, he held positions such as Chief Executive Officer at FASTNET Corp.
and Viventia Biotech, Inc. He was also the Chief Executive Officer-Merchant Banking Division at Burrill LLC from 2011 to 2015.
From 2016 to 2018, he served as the President, Chief Executive Officer & Director at Sesen Bio, Inc. He has also held the position of Chief Executive Officer at Burrill Securities LLC and President, Chief Executive Officer & Director at Viventia Bio, Inc. from 2015 to 2016.
Earlier in his career, he worked as a Managing Director at JPMorgan Securities LLC, Janney Montgomery Scott LLC, and Boenning & Scattergood, Inc. (Broker).
He was a Vice President at Hambrecht & Quist Venture Partners and Wasserstein Perella & Co., Inc. He also worked as an Associate at UBS Investment Bank (US).
Mr. Hurly completed his undergraduate degree from Swarthmore College in 1990 and obtained an MBA from The University of Chicago Booth School of Business in 1997.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LAVA THERAPEUTICS NV
0.02% | 28-02-2023 | 5 000 ( 0.02% ) | 16 650 $ | 31-03-2024 |
Actieve functies van Stephen Allen Hurly
| Bedrijven | Functie | Begin |
|---|---|---|
| LAVA THERAPEUTICS N.V. | Chief Executive Officer | 01-06-2019 |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Phusis Therapeutics, Inc. is a private company that specializes in molecule therapeutics for cancer therapy. The company is based in Houston, TX and was founded by D. Lynn Kirkpatrick. The company focuses on developing inhibitors for PLEKHA7, RAL, Tiam1, and CERK, which are all important in cancer treatment. | Director/Board Member | 01-05-2011 |
Eerdere bekende functies van Stephen Allen Hurly
| Bedrijven | Functie | Einde |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Chief Executive Officer | 07-08-2018 |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Chief Executive Officer | 01-01-2018 |
Viventia Bio, Inc.
 Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Chief Executive Officer | 01-09-2016 |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Corporate Officer/Principal | 01-08-2015 |
Boenning & Scattergood, Inc. (Broker)
 Boenning & Scattergood, Inc. (Broker) Investment Banks/BrokersFinance Boenning & Scattergood, Inc. (Broker) (Boenning & Scattergood-Broker) is the registered broker-dealer division of Boenning & Scattergood, Inc., a financial services firm headquartered in West Conshohocken, Pennsylvania. The firm was founded by Henry D. Boenning in 1914. Boenning & Scattergood-Broker provides retail investors, municipal clients, and institutions a full complement of financial services, including retail brokerage, investment advisory, equity research, equity and fixed income sales and trading, investment banking, public finance, and option strategy. | Corporate Officer/Principal | 30-06-2011 |
Opleiding van Stephen Allen Hurly
| Swarthmore College | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LAVA THERAPEUTICS N.V. | Health Technology |
| Bedrijven in privébezit | 13 |
|---|---|
FASTNET Corp.
 FASTNET Corp. Specialty TelecommunicationsCommunications FASTNET Corporation, an Internet services company based in Bethlehem, PA, is building broadband and wireless infrastructure in high-growth secondary markets to provide high-speed, dedicated and reliable Internet service to businesses of all sizes | Communications |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Hambrecht & Quist Venture Partners
 Hambrecht & Quist Venture Partners Investment ManagersFinance Hambrecht & Quist Venture Partners is a venture capital firm founded in 1983. The firm is headquartered in San Francisco, California. | Finance |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
Janney Montgomery Scott LLC
 Janney Montgomery Scott LLC Investment Banks/BrokersFinance Founded in 1999 by the late Thomas Watson, Janney Montgomery Scott LLC (JMS) is a full-service financial services firm and registered broker/dealer headquartered in Philadelphia, Pennsylvania. The firm is a subsidiary of Independence Square Properties LLC, itself a subsidiary of Penn Mutual Insurance Co. Their ultimate parent is Harleysville Mutual Insurance Co. JMS is a member of the NYSE, the SIPC and FINRA. The firm provides comprehensive financial advice and services to individual, corporate and institutional investors. Their primary coverage verticals include the consumer, technology, financials and infrastructure sectors. | Finance |
Boenning & Scattergood, Inc. (Broker)
Boenning & Scattergood, Inc. (Broker) Investment Banks/BrokersFinance Boenning & Scattergood, Inc. (Broker) (Boenning & Scattergood-Broker) is the registered broker-dealer division of Boenning & Scattergood, Inc., a financial services firm headquartered in West Conshohocken, Pennsylvania. The firm was founded by Henry D. Boenning in 1914. Boenning & Scattergood-Broker provides retail investors, municipal clients, and institutions a full complement of financial services, including retail brokerage, investment advisory, equity research, equity and fixed income sales and trading, investment banking, public finance, and option strategy. | Finance |
| Wasserstein Perella & Co., Inc. | |
UBS Investment Bank (US)
 UBS Investment Bank (US) Investment Banks/BrokersFinance UBS Investment Bank provides investment banking and securities brokerage services. Its clients include institutional and corporate clients, intermediaries, governments, and hedge funds. The firm also provides merger and acquisition advisory, private placement, investment research, foreign exchange, equity, and leverage finance advisory services. The firm is headquartered in San Francisco, CA. | Finance |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| Burrill Securities LLC | Finance |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Phusis Therapeutics, Inc. is a private company that specializes in molecule therapeutics for cancer therapy. The company is based in Houston, TX and was founded by D. Lynn Kirkpatrick. The company focuses on developing inhibitors for PLEKHA7, RAL, Tiam1, and CERK, which are all important in cancer treatment. | Health Technology |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Health Technology |
